Cellectis (CLLS) Return on Sales (2015 - 2026)

Cellectis (CLLS) recorded quarterly Return on Sales of 0.02% in Q1 2026, up 82.02% quarter-over-quarter from 0.08% in Q4 2025, and down 2.0% on a YoY basis from 0.02% in Q1 2025.

Cellectis (CLLS) Return on Sales (2015 - 2026) Analysis & Trends

Cellectis' Return on Sales history runs 12 years deep, the most recent figure standing at 0.02% for Q1 2026.

  • In Q1 2026, Return on Sales fell 2.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2023 annual figure was 0.11%, up 12.0% from the prior year.
  • Return on Sales was 0.02% for Q1 2026 at Cellectis, up from 0.08% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.74% in Q2 2023 to a low of 0.34% in Q1 2023.
  • Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.0% in 2025.
  • Biggest YoY gain for Return on Sales was 74 bps in 2023; the steepest drop was 30 bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then surged by 6334 bps to 0.11% in 2023, then plunged by 125 bps to 0.03% in 2024, then plunged by 208 bps to 0.08% in 2025, then soared by 82 bps to 0.02% in 2026.
  • The last three Return on Sales figures came in at 0.02% (Q1 2026), 0.08% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cellectis 17.40 Bn 17.21 Bn - -0.02%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.02%
Dec 31, 2025 -0.08%
Sep 30, 2025 0.01%
Jun 30, 2025 0.01%
Mar 31, 2025 0.00%
Dec 31, 2024 -0.03%
Sep 30, 2024 0.02%
Mar 31, 2024 0.03%
Dec 31, 2023 0.11%
Sep 30, 2023 0.00%
Jun 30, 2023 0.74%
Mar 31, 2023 -0.34%
Dec 31, 2022 0.00%
Sep 30, 2022 -0.33%
Jun 30, 2022 0.00%
Mar 31, 2022 -0.04%
Dec 31, 2021 -0.01%
Sep 30, 2021 -0.05%
Jun 30, 2021 -0.03%
Mar 31, 2021 0.00%